Prognostic impact of Ikaros expression in lenalidomide-treated multiple myeloma

Oncotarget. 2017 Nov 21;8(63):106163-106164. doi: 10.18632/oncotarget.22572. eCollection 2017 Dec 5.

Authors

Jan Krönke¹, Stefan Knop¹, Christian Langer¹

Affiliation

¹ Jan Krönke: Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany.

No abstract available

Keywords: gene expression; ikaros; lenalidomide; multiple myeloma; prognostic marker.

Publication types

Editorial